Company:  SINOVAC BIOTECH LTD (SVA)
Form Type:  20-F
Filing Date:  5/11/2018 
CIK:  0001084201 
Address:  NO. 39 SHANGDI XI ROAD
HAIDIAN DISTRICT 
City, State, Zip:  BEIJING,  100085 
Telephone:  86-10-82890088 
Fiscal Year:  12/31 
Description of Business
Our legal and commercial name is Sinovac Biotech Ltd. Our principal executive offices are located at No. 39 Shangdi Xi Road, Haidian District, Beijing 100085, PRC. Our telephone number at this address is +86-10-5693-1800. Our registered address is located at the office of APN Corporate and Management Services Limited, Unit #4 Bryson's Complex, Friars Hill Road, St. John's, Antigua. Our agent for service of process in the United States is Cogency Global Inc., located at 122 East 42nd Street, 18th Floor, New York, NY 10168. We are a holding company and conduct our business through our 73.09% majority-owned subsidiary Sinovac Beijing, our 59.24% majority-owned subsidiary Sinovac LS, our 68% majority-owned subsidiary Sinovac Dalian, and our wholly owned subsidiaries Sinovac Biomed, Sinovac Hong Kong and Sinovac Biotech (Singapore) Pte. Ltd. ("Sinovac Singapore").
Register and access this filing in:     
  FORM 20-F
    PART I
      ITEM 1. Identity of Directors, Senior Management and Advisers
      ITEM 2. Offer Statistics and Expected Timetable
      ITEM 3. Key Information
        INCOME STATEMENT
      ITEM 4. Information on the Company
      ITEM 4A. Unresolved Staff Comments
      ITEM 5. Operating and Financial Review and Prospects
        RESULTS OF OPERATIONS
        B. Liquidity and Capital Resources
      ITEM 6. Directors, Senior Management and Employees
        NAME AND TITLE
        OPTIONS
        BENEFICIAL OWNERS
      ITEM 7. Major Shareholders and Related Party Transactions
      ITEM 8. Financial Information
      ITEM 9. The Offer and Listing
      ITEM 10. Additional Information
      ITEM 11. Quantitative and Qualitative Disclosures about ...
      ITEM 12. Description of Securities other than Equity Securities
    PART II
      ITEM 13. Defaults, Dividend Arrearages and Delinquencies
      ITEM 14. Material Modifications to the Rights of Security ...
      ITEM 15. Controls and Procedures
      ITEM 16A. Audit Committee Financial Expert
      ITEM 16B. Code of Ethics
      ITEM 16C. Principal Accountant Fees and Services
      ITEM 16D. Exemptions from the Listing Standards for Audit ...
      ITEM 16E. Purchases of Equity Securities by the Issuer and ...
      ITEM 16F. Change in Registrant's Certifying Accountant
      ITEM 16G. Corporate Governance
      ITEM 16H. Mine Safety Disclosure
    PART III
      ITEM 17. Financial Statements
      ITEM 18. Financial Statements
      ITEM 19. EXHIBITS
    SIGNATURES
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    BALANCE SHEET
    STOCKHOLDERS EQUITY
    STOCKHOLDERS EQUITY
    STOCKHOLDERS EQUITY
    CASH FLOW
    Notes to Consolidated Financial Statements
    BENEFICIAL OWNERS
    BALANCE SHEET
    CASH FLOW
  EXHIBIT 4.5
  EXHIBIT 8.1
  EXHIBIT 12.1
  EXHIBIT 12.2
  EXHIBIT 13.1
  EXHIBIT 13.2
  EXHIBIT 15.1


EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.